A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO
for Neovascular Age-Related Macular Degeneration (NVAMD)
49 locations incl. Scottsdale
Sponsor: EyeBiotech Ltd.
Sex: All·Age: 18+
Code: NCT07205887·Phase 2·Recruiting·Listed Oct 2025